CVS Health Corporation (CVS) is a Consumer Discretionary stock trading at $107.59 (as of 2026-07-20), with a market capitalization of $137.28B and a trailing P/E of 77.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
CVS Health Corporation provides health services in the United States through a Health Care Benefits segment offering health insurance products and related services, and a Pharmacy Services segment offering pharmacy benefit management and related pharmacy, specialty, and clinical/disease management services. It serves employer groups, individuals and other plan sponsors, health plans, providers, government-related entities, and certain retail and pharmacy customers.
CVS Health provides health services in the United States, it sells health insurance products and related services through its Health Care Benefits segment and it also provides pharmacy benefit management and related pharmacy and network services through its Pharmacy Services segment.
CVS earns money by combining two connected levers in one platform, Health Care Benefits (insurance products and services) and Pharmacy Services (pharmacy benefit management and pharmacy network operations), so changes in member demand and prescription-related activity can flow through both revenue streams.
| Health Benefits | $36.0B |
| Pharmacy Services | $64.4B |
Business quality (Weak): The company has a clear, dual business model (insurance and pharmacy services) with a modest overall operating margin (4.7% in the latest period provided), which makes cost control and ongoing demand for its services central to results.
Valuation: At 45× earnings, CVS trades 134% above the Retail average (19×). Note: one-time items can distort reported P/E.
| Price | $107.59 |
| Market Cap | $137.28B |
| P/E Ratio | 77.9 |
| EV / EBITDA | 10.8 |
| Price / Book | 1.77 |
| Price / Sales | 0.35 |
| FCF Yield | 12.8% |
| DCF Value (model) | $34.99 |
| DCF Upside vs Price | -67.5% |
| Revenue (TTM) | $402.07B |
| Net Margin | 0.4% |
| Revenue Growth (YoY) | 7.8% |
| EPS Growth (YoY) | -61.9% |
| FCF Growth (YoY) | 23.4% |
| Altman Z-Score | 2.38 (grey) |
| Piotroski F-Score | 7/9 (strong) |
| Stock P/E | 77.9 |
| Sector P/E (Consumer Discretionary) | 21.6 |
| Industry P/E (Retail) | 19.1 |
| vs Sector | 261.3% |
| vs Industry | 307.1% |
| Top Institutional Holder | VANGUARD GROUP INC ($9.58B) |
| Institutional Holders Tracked | 10 |
| Congressional Trades (recent) | 10 |
| Sector | Consumer Discretionary |
| Industry | Retail |
| CEO | J. David Joyner |
| Employees | 219,000 |
| Country | US |
| IPO Date | 1996-11-20 |
Data as of 2026-07-20.
Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.